Showing 5591-5600 of 8473 results for "".
- Neutrogena® Launches First-Ever Global Beauty Campaignhttps://practicaldermatology.com/news/neutrogena-launches-first-ever-global-beauty-campaign/2458684/Neutrogena® is set to debut their first-ever global campaign: “Neutrogena. See What’s Possible.™” A commercial voiced by Brand Ambassador and creative consultant Kerry Washington will fe
- Botox Helps Fuel Allergan's “Better-Than-Expected” Q4 Earningshttps://practicaldermatology.com/news/botox-helps-fuel-allergans-better-than-expected-q4-earnings/2458687/Allergan is reporting “better-than-expected” fourth-quarter earnings, largely fueled by Botox. The company saw a 74 percent increase in Q4 net revenue to $4.2 Billion for Q4 2015, topping the nearly $4.18 billion consensus estimate of S&a
- Galderma Mans Up with New Cetaphil Line for Menhttps://practicaldermatology.com/news/cetaphils-newest-line-targets-men/2458690/Galderma Laboratories, L.P is manning up with the launch of a new skin care line for men. The Cetaphil® Men line comprises Cetaphil® Men Daily Face Wash, Cetaphil® M
- Good Deal: DS Healthcare Acquires Radiancy, Neovahttps://practicaldermatology.com/news/good-deal-ds-healthcare-acquires-radiancy-neova/2458692/DS Healthcare Group, Inc. will acquire Radiancy, Inc., and Neova® from PhotoMedex, Inc. The board of directors of both companies have voted unanimously in favor o
- Sweet Acne Cure: Kanuka Honey from New Zealand May Eradicate Acnehttps://practicaldermatology.com/news/sweet-acne-cure-kanuka-honey-from-new-zealand-may-eradicate-acne/2458693/Kanuka honey may help out the brakes on acne, new research suggests. In the study of Honevo®, developed by New Zealand pharmaceutical company HoneyLab, twice as many participants had an imp
- Dr. Bruce Strober Appointed Chair of Dermatology at UConn Healthhttps://practicaldermatology.com/news/dr-bruce-strober-appointed-chair-of-dermatology-at-uconn-health/2458694/Bruce E. Strober, MD, PhD has been appointed chair of the Department of Dermatology at UConn Health and professor of dermatology at UConn School of Medicine. Dr. Strober has served as the interim chair of the Department of Dermatology since 2015 and vice chair since joining UConn Health in 2011.
- Hidradenitis Suppurativa Ups Risk of Adverse CV Eventshttps://practicaldermatology.com/news/hidradenitis-suppurativa-ups-risk-of-adverse-cv-events/2458696/Hidradenitis suppurativa (HS) may increase risk for adverse cardiovascular outcomes, a new study suggests. HS has been associated with cardiovascular risk factors, such as smoking and obesity, but the risk of cardiovascular disease in patients with HS was unknown. The new study
- Sturge-Weber Foundation to Host Dermatology Roundtablehttps://practicaldermatology.com/news/sturge-weber-foundation-to-host-dermatology-roundtable/2458697/The Sturge-Weber Foundation (SWF) is holding a Dermatology Discussion Roundtable meeting on March 5, 2016, at the Marriott Marquis in Washington, DC. Attendees of the American Academy of Dermatology (AAD) conference are invited to attend this breakfast meeting from 7:30 a.m. to 9:30 a.m. in the J
- Hilary Baldwin, MD, Named Medical Director of ATRChttps://practicaldermatology.com/news/hilary-baldwin-md-named-medical-director-of-atrc/2458710/The newly opened Acne Treatment and Research Center (ATRC) in Morristown, NJ, has tapped Hilary Baldwin, MD, to serve as its medical director. Dr. Baldwin received her BA and MA in biology from Boston Uni
- Pfizer Outlines Post-Allergan Deal Leadership Team Changeshttps://practicaldermatology.com/news/pfizer-outlines-post-allergan-deal-leadership-team-changes/2458709/Brent Saunders will become President and Chief Operating Officer of the combined Pfizer and Allergan company following the close of the merger deal. In this role, he will over see Pfizer and Allergan’s combined commercial businesses, manufacturing and strategy functions. The c